123 related articles for article (PubMed ID: 2120389)
21. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease.
Hattingen E; Magerkurth J; Pilatus U; Mozer A; Seifried C; Steinmetz H; Zanella F; Hilker R
Brain; 2009 Dec; 132(Pt 12):3285-97. PubMed ID: 19952056
[TBL] [Abstract][Full Text] [Related]
22. Structure and function of mitochondria: their organization and disorders.
Ozawa T; Tanaka M; Suzuki H; Nishikimi M
Brain Dev; 1987; 9(2):76-81. PubMed ID: 2888415
[TBL] [Abstract][Full Text] [Related]
23. Mitochondria in the etiology and pathogenesis of Parkinson's disease.
Schapira AH; Gu M; Taanman JW; Tabrizi SJ; Seaton T; Cleeter M; Cooper JM
Ann Neurol; 1998 Sep; 44(3 Suppl 1):S89-98. PubMed ID: 9749579
[TBL] [Abstract][Full Text] [Related]
24. [A mitochondrial encephalomyopathy: a case of a defect of complex I in the electron transport chain].
Shinozawa K; Nishizawa M; Tanaka K; Atsumi T; Ohama E
Rinsho Shinkeigaku; 1987 Jan; 27(1):41-8. PubMed ID: 3105942
[No Abstract] [Full Text] [Related]
25. Assembly of NADH: ubiquinone reductase (complex I) in Neurospora mitochondria. Independent pathways of nuclear-encoded and mitochondrially encoded subunits.
Tuschen G; Sackmann U; Nehls U; Haiker H; Buse G; Weiss H
J Mol Biol; 1990 Jun; 213(4):845-57. PubMed ID: 2141652
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial energy crisis in Parkinson's disease.
Mizuno Y; Ikebe S; Hattori N; Kondo T; Tanaka M; Ozawa T
Adv Neurol; 1993; 60():282-7. PubMed ID: 8420144
[No Abstract] [Full Text] [Related]
27. Mitochondrial dysfunction--a pathogenetic factor in Parkinson's disease.
Reichmann H; Janetzky B
J Neurol; 2000 Apr; 247 Suppl 2():II63-8. PubMed ID: 10991668
[TBL] [Abstract][Full Text] [Related]
28. Origin and functional consequences of the complex I defect in Parkinson's disease.
Swerdlow RH; Parks JK; Miller SW; Tuttle JB; Trimmer PA; Sheehan JP; Bennett JP; Davis RE; Parker WD
Ann Neurol; 1996 Oct; 40(4):663-71. PubMed ID: 8871587
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia.
Schapira AH
Biochim Biophys Acta; 1999 Feb; 1410(2):159-70. PubMed ID: 10076024
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.
Hattori N; Tanaka M; Ozawa T; Mizuno Y
Ann Neurol; 1991 Oct; 30(4):563-71. PubMed ID: 1665052
[TBL] [Abstract][Full Text] [Related]
31. Absence of 4,977-bp deletion of blood cell mitochondrial DNA in patients with young-onset Parkinson's disease.
Shan DE; Yeh SI; Wan YC; Wei YH
Acta Neurol Scand; 1995 Feb; 91(2):149-52. PubMed ID: 7785427
[TBL] [Abstract][Full Text] [Related]
32. Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients.
DiDonato S; Zeviani M; Giovannini P; Savarese N; Rimoldi M; Mariotti C; Girotti F; Caraceni T
Neurology; 1993 Nov; 43(11):2262-8. PubMed ID: 8232940
[TBL] [Abstract][Full Text] [Related]
33. Aldehyde dehydrogenase 2 in sporadic Parkinson's disease.
Michel TM; Käsbauer L; Gsell W; Jecel J; Sheldrick AJ; Cortese M; Nickl-Jockschat T; Grünblatt E; Riederer P
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S68-72. PubMed ID: 24262192
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders.
Gu G; Reyes PE; Golden GT; Woltjer RL; Hulette C; Montine TJ; Zhang J
J Neuropathol Exp Neurol; 2002 Jul; 61(7):634-9. PubMed ID: 12125742
[TBL] [Abstract][Full Text] [Related]
35. No evidence for altered muscle mitochondrial function in Parkinson's disease.
Anderson JJ; Bravi D; Ferrari R; Davis TL; Baronti F; Chase TN; Dagani F
J Neurol Neurosurg Psychiatry; 1993 May; 56(5):477-80. PubMed ID: 8505638
[TBL] [Abstract][Full Text] [Related]
36. The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction.
Kösel S; Egensperger R; Schnopp NM; Graeber MB
Mov Disord; 1997 Sep; 12(5):639-45. PubMed ID: 9380043
[TBL] [Abstract][Full Text] [Related]
37. L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain.
Cooper JM; Daniel SE; Marsden CD; Schapira AH
Mov Disord; 1995 May; 10(3):295-7. PubMed ID: 7651446
[TBL] [Abstract][Full Text] [Related]
38. Respiratory chain and mitochondrial deoxyribonucleic acid in blood cells from patients with focal and generalized dystonia.
Reichmann H; Naumann M; Hauck S; Janetzky B
Mov Disord; 1994 Nov; 9(6):597-600. PubMed ID: 7845398
[TBL] [Abstract][Full Text] [Related]
39. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
Dexter DT; Sian J; Rose S; Hindmarsh JG; Mann VM; Cooper JM; Wells FR; Daniel SE; Lees AJ; Schapira AH
Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590
[TBL] [Abstract][Full Text] [Related]
40. What process causes nigral cell death in Parkinson's disease?
Jenner P
Neurol Clin; 1992 May; 10(2):387-403. PubMed ID: 1584181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
